CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 891 - 900 of 939
Study Number Lead Group Study Title CIRB Study Status
S1501 SWOG Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer; Phase III Cancer Prevention and Control CIRB Available to Open
MAY2016-07-01 CLO-Mayo Clinic Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis Cancer Prevention and Control CIRB Available to Open
MAY2015-05-01 CLO-Mayo Clinic Randomized, double-blind, placebo-controlled trial of Meriva® (curcuminoids) as a candidate chemoprevention agent for gastric carcinogenesis Cancer Prevention and Control CIRB Available to Open
MAY2016-08-01 CLO-Mayo Clinic A Pilot Study of MUC1 Vaccine in Current and Former Smokers at High Risk for Lung Cancer Cancer Prevention and Control CIRB Available to Open
MAY2017-09-01 CLO-Mayo Clinic Phase I Double-Blind, Placebo-Controlled Trial of 27 mg Dolcanatide (SP-333) to Demonstrate Colorectal Bioactivity in Healthy Volunteers Cancer Prevention and Control CIRB Available to Open
MDA2016-08-02 CLO-MD Anderson A Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer Cancer Prevention and Control CIRB Available to Open
MDA2016-07-02 CLO-MD Anderson A Randomized, Double-blind, Placebo-controlled Study of 4-hydroxytamoxifen Topical Gel in Women with Mammographically Dense Breast Cancer Prevention and Control CIRB Available to Open
MDA2014-04-01 CLO-MD Anderson Alternative Dosing of Exemestane in Postmenopausal Women with Stage 0-II ER-Positive Breast Cancer: a Randomized Presurgical Trial Cancer Prevention and Control CIRB Available to Open
MDA2017-09-03 CLO-MD Anderson Pilot Study of Denosumab in BRCA1/2 Mutation Carriers scheduled for Risk-reducing Salpingooophorectomy Cancer Prevention and Control CIRB Available to Open
MDA2014-04-02 CLO-MD Anderson VADIS Trial: Phase II trial of Nelipepimut-S Peptide Vaccine in Women with DCIS of the Breast Cancer Prevention and Control CIRB Available to Open
Displaying 891 - 900 of 939